vs
丹纳赫（DHR）与Raymond James Financial（RJF）财务数据对比。点击上方公司名可切换其他公司
丹纳赫的季度营收约是Raymond James Financial的1.5倍（$6.0B vs $3.9B），丹纳赫净利率更高（17.3% vs 14.1%，领先3.2%），Raymond James Financial同比增速更快（13.0% vs 3.7%），过去两年丹纳赫的营收复合增速更高（1.8% vs 1.3%）
丹纳赫是总部位于美国华盛顿特区的医疗健康企业，聚焦生物技术、生命科学与诊断领域的产品研发。公司下设三大业务板块：生物技术板块开发治疗相关产品，生命科学板块覆盖疾病溯源、新疗法研发、药物疫苗与基因编辑技术的测试生产，诊断板块研发检测仪器，为全球生命健康产业提供核心支持。
雷蒙德詹姆斯金融是美国跨国独立投资银行及金融服务机构，通过旗下子公司为个人、企业及市政主体提供多元金融服务，核心业务覆盖投资与财务规划、投资银行、资产管理等领域，总部位于美国佛罗里达州圣彼得堡。
DHR vs RJF — 直观对比
营收规模更大
DHR
是对方的1.5倍
$3.9B
营收增速更快
RJF
高出9.3%
3.7%
净利率更高
DHR
高出3.2%
14.1%
两年增速更快
DHR
近两年复合增速
1.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $6.0B | $3.9B |
| 净利润 | $1.0B | $544.0M |
| 毛利率 | 60.3% | — |
| 营业利润率 | 22.6% | — |
| 净利率 | 17.3% | 14.1% |
| 营收同比 | 3.7% | 13.0% |
| 净利润同比 | 7.9% | 10.0% |
| 每股收益（稀释后） | $1.45 | $2.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHRRJF
| Q1 26 | $6.0B | $3.9B | ||
| Q4 25 | $6.8B | $4.2B | ||
| Q3 25 | $6.1B | $4.2B | ||
| Q2 25 | $5.9B | $3.8B | ||
| Q1 25 | $5.7B | $3.8B | ||
| Q4 24 | $6.5B | $4.0B | ||
| Q3 24 | $5.8B | $4.0B | ||
| Q2 24 | $5.7B | $3.8B |
净利润DHRRJF
| Q1 26 | $1.0B | $544.0M | ||
| Q4 25 | $1.2B | $563.0M | ||
| Q3 25 | $908.0M | $604.0M | ||
| Q2 25 | $555.0M | $436.0M | ||
| Q1 25 | $954.0M | $495.0M | ||
| Q4 24 | $1.1B | $600.0M | ||
| Q3 24 | $818.0M | $602.0M | ||
| Q2 24 | $907.0M | $492.0M |
毛利率DHRRJF
| Q1 26 | 60.3% | — | ||
| Q4 25 | 58.0% | — | ||
| Q3 25 | 58.2% | — | ||
| Q2 25 | 59.3% | — | ||
| Q1 25 | 61.2% | — | ||
| Q4 24 | 59.5% | — | ||
| Q3 24 | 58.7% | — | ||
| Q2 24 | 59.7% | — |
营业利润率DHRRJF
| Q1 26 | 22.6% | — | ||
| Q4 25 | 22.0% | — | ||
| Q3 25 | 19.1% | — | ||
| Q2 25 | 12.8% | 14.7% | ||
| Q1 25 | 22.2% | 17.5% | ||
| Q4 24 | 21.8% | 18.6% | ||
| Q3 24 | 16.5% | — | ||
| Q2 24 | 20.3% | 17.1% |
净利率DHRRJF
| Q1 26 | 17.3% | 14.1% | ||
| Q4 25 | 17.5% | 13.5% | ||
| Q3 25 | 15.0% | 14.4% | ||
| Q2 25 | 9.3% | 11.3% | ||
| Q1 25 | 16.6% | 12.9% | ||
| Q4 24 | 16.6% | 14.9% | ||
| Q3 24 | 14.1% | 15.0% | ||
| Q2 24 | 15.8% | 13.1% |
每股收益（稀释后）DHRRJF
| Q1 26 | $1.45 | $2.83 | ||
| Q4 25 | $1.69 | $2.79 | ||
| Q3 25 | $1.27 | $2.96 | ||
| Q2 25 | $0.77 | $2.12 | ||
| Q1 25 | $1.32 | $2.36 | ||
| Q4 24 | $1.50 | $2.86 | ||
| Q3 24 | $1.12 | $2.85 | ||
| Q2 24 | $1.22 | $2.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $5.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $52.0M |
| 总资产 | — | $91.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DHRRJF
| Q1 26 | — | $5.4B | ||
| Q4 25 | — | $9.9B | ||
| Q3 25 | — | $11.4B | ||
| Q2 25 | — | $9.2B | ||
| Q1 25 | — | $9.7B | ||
| Q4 24 | — | $10.0B | ||
| Q3 24 | — | $11.0B | ||
| Q2 24 | — | $9.1B |
总债务DHRRJF
| Q1 26 | — | — | ||
| Q4 25 | $18.4B | — | ||
| Q3 25 | $16.9B | — | ||
| Q2 25 | $17.4B | — | ||
| Q1 25 | $16.5B | — | ||
| Q4 24 | $16.0B | — | ||
| Q3 24 | $17.5B | — | ||
| Q2 24 | $17.0B | — |
股东权益DHRRJF
| Q1 26 | — | $52.0M | ||
| Q4 25 | $52.5B | $12.6B | ||
| Q3 25 | $51.1B | $12.5B | ||
| Q2 25 | $52.3B | $12.3B | ||
| Q1 25 | $50.8B | $12.2B | ||
| Q4 24 | $49.5B | $11.9B | ||
| Q3 24 | $51.3B | $11.7B | ||
| Q2 24 | $49.9B | $11.2B |
总资产DHRRJF
| Q1 26 | — | $91.9B | ||
| Q4 25 | $83.5B | $88.8B | ||
| Q3 25 | $79.9B | $88.2B | ||
| Q2 25 | $81.6B | $84.8B | ||
| Q1 25 | $79.1B | $83.1B | ||
| Q4 24 | $77.5B | $82.3B | ||
| Q3 24 | $80.6B | $83.0B | ||
| Q2 24 | $78.6B | $80.6B |
负债/权益比DHRRJF
| Q1 26 | — | — | ||
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.33× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.32× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | — |
| 自由现金流经营现金流 - 资本支出 | $1.1B | — |
| 自由现金流率自由现金流/营收 | 18.2% | — |
| 资本支出强度资本支出/营收 | 4.0% | — |
| 现金转化率经营现金流/净利润 | 1.28× | — |
| 过去12个月自由现金流最近4个季度 | $5.3B | — |
8季度趋势，按日历期对齐
经营现金流DHRRJF
| Q1 26 | $1.3B | — | ||
| Q4 25 | $2.1B | $-10.0M | ||
| Q3 25 | $1.7B | $796.0M | ||
| Q2 25 | $1.3B | $691.0M | ||
| Q1 25 | $1.3B | $117.0M | ||
| Q4 24 | $2.0B | $830.0M | ||
| Q3 24 | $1.5B | $510.0M | ||
| Q2 24 | $1.4B | $711.0M |
自由现金流DHRRJF
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.7B | $-56.0M | ||
| Q3 25 | $1.4B | $752.0M | ||
| Q2 25 | $1.1B | $634.0M | ||
| Q1 25 | $1.1B | $71.0M | ||
| Q4 24 | $1.5B | $789.0M | ||
| Q3 24 | $1.2B | $460.0M | ||
| Q2 24 | $1.1B | $655.0M |
自由现金流率DHRRJF
| Q1 26 | 18.2% | — | ||
| Q4 25 | 25.5% | -1.3% | ||
| Q3 25 | 22.6% | 17.9% | ||
| Q2 25 | 18.4% | 16.5% | ||
| Q1 25 | 18.4% | 1.8% | ||
| Q4 24 | 23.0% | 19.6% | ||
| Q3 24 | 21.0% | 11.5% | ||
| Q2 24 | 19.7% | 17.4% |
资本支出强度DHRRJF
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.4% | 1.1% | ||
| Q3 25 | 4.8% | 1.1% | ||
| Q2 25 | 4.2% | 1.5% | ||
| Q1 25 | 4.3% | 1.2% | ||
| Q4 24 | 7.9% | 1.0% | ||
| Q3 24 | 5.1% | 1.2% | ||
| Q2 24 | 5.0% | 1.5% |
现金转化率DHRRJF
| Q1 26 | 1.28× | — | ||
| Q4 25 | 1.77× | -0.02× | ||
| Q3 25 | 1.83× | 1.32× | ||
| Q2 25 | 2.41× | 1.58× | ||
| Q1 25 | 1.36× | 0.24× | ||
| Q4 24 | 1.86× | 1.38× | ||
| Q3 24 | 1.85× | 0.85× | ||
| Q2 24 | 1.56× | 1.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHR
暂无分部数据
RJF
| Private Client Group | $2.8B | 73% |
| Bank | $486.0M | 13% |
| Capital Markets | $464.0M | 12% |
| Other | $99.0M | 3% |
